Advanced lens technology for controlling childhood myopia
optiMYOPE+ is the next generation of myopia management lenses, designed to slow the progression of short-sightedness in children. Built upon years of research and innovation, it offers a clinically proven optical approach to managing myopia and reducing the risks associated with its progression.

optiMYOPE+ builds on the success of its predecessor with a refined, evidence-based design that not only slows the rate of myopic increase, but also actively counters ocular elongation – a key factor in long-term eye health.

Using a unique design that accounts for the natural asymmetry of the retina across nasal and temporal regions, optiMYOPE+ delivers personalised myopia control. It supports accurate image placement on the retina while maintaining excellent central vision, providing a balance of comfort, clarity and therapeutic benefit.

• Clinically supported: Designed using peer-reviewed research and clinical data
• Dual-action technology: Targets both myopic progression and ocular elongation
• Anatomically adapted: Accounts for nasal-temporal retinal asymmetry
• Clear central vision: Maintains comfort and visual performance
• Suitable for younger wearers: A safe, non-invasive option for paediatric myopia management